ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis

Tervonen, Tommi*; Vora, Pareen; Seo, Jaein; Krucien, Nicolas; Marsh, Kevin; De Caterina, Raffaele; Wissinger, Ulrike; Soriano Gabarro, Montse
Patient-Patient Centered Outcomes Research2021-9DOI: 10.1007/s40271-021-00506-2
2被引1阅读
引用收藏
分享

摘要

Background Patients taking low-dose aspirin to prevent cardiovascular disease (CVD) may also benefit from a reduced risk of colorectal cancer (CRC). Objective The aim was to examine the preferences of people eligible for preventive treatment with low-dose aspirin and the trade-offs they are willing to make between CVD prevention, CRC prevention, and treatment risks. Methods A cross-sectional study using a discrete choice experiment (DCE) survey was conducted in Italy in 2019 to elicit preferences for three benefit attributes (prevention of ischemic stroke, myocardial infarction, and CRC) and four risk attributes (intracranial and gastrointestinal bleeding, peptic ulcer, and severe allergic reaction) associated with use of low-dose aspirin. Latent class logit models were used to evaluate variation in treatment preferences. Results The DCE survey was completed by 1005 participants eligible for use of low-dose aspirin. A four-class model had the best fit for the primary CVD prevention group (n = 491), and a three-class model had the best fit for the secondary CVD prevention group (n = 514). For the primary CVD prevention group, where classes differed on age, education level, type 2 diabetes, exercise, and low-dose aspirin use, the most important attributes were intracranial bleeding (two classes), myocardial infarction (one class), and CRC (one class). For the secondary CVD prevention group, where classes differed on various comorbidities, self-reported health, exercise, and CVD medication use, the most important attributes were intracranial bleeding (two classes), myocardial infarction (one class), and gastrointestinal bleeding (one class). Conclusion Patient preferences for the benefits and risks of low-dose aspirin differ significantly among people eligible for treatment as primary or secondary CVD prevention.

学科与关键词

关键词
DISCRETE-CHOICE EXPERIMENTSATRIAL-FIBRILLATIONCONJOINT-ANALYSISSTATISTICAL PROPERTIESFOLLOW-UPHEALTHRISKPHYSICIANTHERAPYBENEFITS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Patient-Patient Centered Outcomes Research
发表日期
2021-09
卷期
第 14 卷, 第 5 期
页码
661-672
DOI
10.1007/s40271-021-00506-2
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Bayer AG

作者

  • T

    Tervonen, Tommi (通讯) (第一作者)

  • V

    Vora, Pareen

查看全部 8 位作者收起作者
  • S

    Seo, Jaein

  • K

    Krucien, Nicolas

  • M

    Marsh, Kevin

  • D

    De Caterina, Raffaele

  • W

    Wissinger, Ulrike

  • S

    Soriano Gabarro, Montse

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417